Morphine sulphate formulations

Details for Australian Patent Application No. 2006247349 (hide)

Owner Alpharma, Inc.

Inventors Liang, Alfred C.

Agent Cullen & Co

Pub. Number AU-A-2006247349

PCT Pub. Number WO2006/124890

Priority 11/159,894 23.06.05 US; 60/680,554 13.05.05 US

Filing date 12 May 2006

Wipo publication date 23 November 2006

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

Event Publications

3 January 2008 PCT application entered the National Phase

  PCT publication WO2006/124890 Priority application(s): WO2006/124890

23 February 2012 Assignment before Grant

  Alpharma, Inc. The application has been assigned to Alpharma Pharmaceuticals LLC

11 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006247351-Modulators of alpha-synuclein toxicity

2006247348-Elastomeric films with brittle nonblocking skins